| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |